Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

3.3K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
3.3K
Vaccines01:21

Vaccines

64
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
64
Vaccinations01:51

Vaccinations

43.7K
Overview
43.7K
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

1.8K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.8K
Cancer Vaccines01:30

Cancer Vaccines

1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Cross-reactivity00:42

Cross-reactivity

28.7K
Overview
28.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AS01<sub>B</sub>-, MF59-, and alum-based adjuvants and HIV vaccine immunogenicity: a <i>post-hoc</i> cross-protocol comparison of results from HVTN 100, 107, 120, and 702.

Frontiers in immunology·2026
Same author

IDSA 2025 Guidelines on the use of vaccines for the prevention of seasonal COVID-19, Influenza, and RSV infections in immunocompromised patients.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

HIV-1 Vpr is targeted for degradation by autophagy.

PLoS pathogens·2026
Same author

IDSA 2025 Guidelines on the use of vaccines for the prevention of seasonal Influenza infections in immunocompromised patients.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

CD8+ T cells cross-restricted by HLA-B*57 and HLA-E*01 recognize HIV Gag with different functional profiles.

JCI insight·2025
Same author

Long COVID trajectories in the prospectively followed RECOVER-Adult US cohort.

Nature communications·2025

Related Experiment Video

Updated: Apr 23, 2026

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model
11:38

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model

Published on: July 2, 2016

9.7K

Human immunodeficiency virus vaccines.

Paul Goepfert1, Anju Bansal2

  • 1Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, 908, 20th Street South, CCB 328, Birmingham, AL 35294, USA.

Infectious Disease Clinics of North America
|October 8, 2014
PubMed
Summary
This summary is machine-generated.

An effective HIV vaccine is crucial for global prevention. Recent trials show modest protection, offering optimism and insights for future HIV vaccine development.

Keywords:
Binding antibodiesDNA primeHIV vaccinesNeutralizing antibodiesProtein boostT cellsViral vector

More Related Videos

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
07:10

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on: September 14, 2014

13.7K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

9.5K

Related Experiment Videos

Last Updated: Apr 23, 2026

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model
11:38

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model

Published on: July 2, 2016

9.7K
Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
07:10

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on: September 14, 2014

13.7K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

9.5K

Area of Science:

  • Immunology
  • Vaccinology
  • Infectious Diseases

Background:

  • Human Immunodeficiency Virus (HIV) remains a global health challenge.
  • Current HIV prevention strategies have limitations; an effective vaccine is paramount.
  • Past HIV vaccine development efforts have faced significant hurdles.

Purpose of the Study:

  • To review the progress in HIV vaccine development.
  • To discuss insights gained from recent vaccine trials.
  • To outline future directions for creating an effective HIV vaccine.

Main Methods:

  • Literature review of HIV vaccine research.
  • Analysis of recent clinical trial outcomes.
  • Discussion of immunological and design considerations.

Main Results:

  • Recent HIV vaccine regimens have demonstrated modest protective efficacy.
  • Despite insufficient efficacy for licensure, trials provide valuable data.
  • Renewed optimism exists within the HIV vaccine research community.

Conclusions:

  • An effective HIV vaccine is essential for global control of HIV-1.
  • Recent trials offer critical lessons for next-generation vaccine design.
  • Continued research is vital to develop a successful HIV preventive vaccine.